MedTrace Logo

Norwegian Constraint-Induced (CI) Therapy Multisite Trial

NCT00906477 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2013-10-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether modified CI therapy treatment is suitable and effective in the early rehabilitation after stroke, and to compare early CI intervention with a later CI intervention group.

Conditions

  • Cerebrovascular Accident

Interventions

PROCEDURE

Modified CI therapy

10 treatment days 3 hours a day: Shaping exercises 2 hours. Task practice 0,5 hours. Behavioral therapy (Transfer package) 0,5 hour. Encouragement to wear a restraining mitt on the least affected arm for all safe activities.

Sponsors & Collaborators

  • Helse Nord

    collaborator INDUSTRY

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Gyrd Thrane, Cand. San. · University Hospital of North Norway

  • Audny GM Anke, MD, PhD · University Hospital of North Norway

  • Bent Indredavik, MD, PhD · Trondheim University Hospital

  • Torunn Askim, PhD · Norwegian University of Technology and Science

  • Roland Stock, MSc · Trondheim University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-01-31
Completion
2013-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00906477 on ClinicalTrials.gov